NEUTROPENIA IN PATIENTS WITH HIV INFECTION: IMPLICATIONS AND METHODS OF CORRECTION
https://doi.org/10.29001/2073-8552-2017-32-2-22-26
Abstract
Neutropenia is a common complication of infection caused by the human immunodeficiency virus (HIV). The etiology of neutropenia in this pathology can be quite different. This is the damage of precursor cells by human immunodeficiency virus (HIV), collapse of bone-marrow hemopoiesis caused by drugs for the HIV treatment and opportunistic infections, displacement of normal hematosis by tumorous HIV-associated cells and accelerated apoptosis of segmented neutrophils. These mechanisms are an important factor of developing opportunistic infection in HIV infected patients. Application of granulocytic colony-stimulating factors during complex therapy of HIV infection provides an opportunity to regulate the amount and the function of neutrophils, reducing the risk of consecutive infections. The article gives an overview of the literature and prospective studies of the author.
About the Authors
I. L. Davydkin
Samara Medical University
Russian Federation
Russian Federation
R. K. Khairetdinov
Samara Medical University
Russian Federation
Russian Federation
O. E. Danilova
Samara Medical University
Russian Federation
Russian Federation
S. P. Krivova
Samara Medical University
Russian Federation
Russian Federation
T. Y. Stepanova
Samara Medical University
Russian Federation
Russian Federation
O. V. Agafonova
Samara Regional Center for Prevention and Control of AIDS and Infectious Diseases
Russian Federation
Russian Federation
J. O. Berman
Samara Medical University
Russian Federation
Russian Federation
References
1. Gilks C.F., Brindle R.J., Otieno L.S. et al. Life-threatening bacteremia in HIV-1-seropositive adults admitted to a hospital in Nairobi, Kenya // Lancet. – 1990. – Vol. 336. – P. 545.
2. Grutzmeier S., Gerstoft J., Hansen B. et al. Filgrastim (G-CSF) use is associated with prolonged survival in AIDS patients with neutropenia and CD4 cells <50×106/L [abstract We.A.3094] // Program and abstracts of the 11th International Conference on AIDS, 7–12 July, Vancouver. – 1996.
3. Hermans P., Rozenbaum W., Jou A. et al. Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection // AIDS. – 2006. – Vol. 10. – P. 1627–33.
4. Castella A., Croxson T.S., Mildvan D. et al. The bone marrow in AIDS: a histologic, hematologic, and microbiologic study // Am. J. Clin. Pathol. – 2005. – Vol. 84. – P. 425–32.
5. Pluda J.M., Mitsuya H., Yarchoan R. Hematologic effects of AIDS therapies // Hematol. Oncol. Clin. North Am. – 2011. – Vol. 5. –P. 229–48.
6. Rule S.A., Hooker M., Costello C. et al. Serum vitamin B12 and transcobalamin levels in early HIV disease // Am. J. Hematology. – 2004. – Vol. 47. – P. 167–71.
7. Pitrak D.L., Tsai H.C., Mullane K.M. et al. Accelerated neutrophil apop-tosis in the acquired immunodeficiency syndrome // J. Clin. Invest. – 2015. – Vol. 98. – P. 2714–9.
8. Pitrak D.L., Bak P.M., DeMarais P. et al. Depressed neutrophil superoxide production in human immunodeficiency virus infection // J. Infect. Dis. – 2003. – Vol. 167. – P. 1406.
9. Hober D., Ajana F., Petit M.C. et al. Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha in patients with human immunodeficiency virus (HIV) type I infection // Microbiol. Immunol. – 1993. – Vol. 37. – P. 785– 92.
10. Herold M., Meise U., Gunther V. et al. Serum concentrations of circula-ting endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users // Presse Med. – 2000. – Vol. 23. – P. 1854–8.
11. Moore R.D., Keruly J., Chaisson R.E. Neutropenia and bacterial infection in acquired immunodeficiency syndrome // Arch. Intern. Med. – 2015. – P. 155.
12. Buhles W.C.Jr., Mastre B.J., Tinker A.J. et al. Ganciclovir treatment of life- or sight- threatening cytomegalovirus infection: experience in 314 immunocompromised patients // Rev. Infect. Dis. – 2013. – Vol. 10, Suppl. 3. – S495–506.
Review
For citations:
Davydkin I.L., Khairetdinov R.K., Danilova O.E., Krivova S.P., Stepanova T.Y., Agafonova O.V., Berman J.O. NEUTROPENIA IN PATIENTS WITH HIV INFECTION: IMPLICATIONS AND METHODS OF CORRECTION. Siberian Journal of Clinical and Experimental Medicine. 2017;32(2):22-26. (In Russ.) https://doi.org/10.29001/2073-8552-2017-32-2-22-26
Views:
1144
.png)
Email this article 